EnteroMedics Inc., (NASDAQ: ETRM) is a St. Paul, MN based medical device company established in 2002 to develop and commercialize a therapeutic neuroblocking platform for treating a range of acute and chronic gastrointestinal and metabolic diseases mediated by the vagus nerve.
http://ir.enteromedics.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
16x16
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
95
SITE IP
206.200.251.19
LOAD TIME
0 sec
SCORE
6.2
EnteroMedics® Inc. - Overview | ir.enteromedics.com Reviews
https://ir.enteromedics.com
EnteroMedics Inc., (NASDAQ: ETRM) is a St. Paul, MN based medical device company established in 2002 to develop and commercialize a therapeutic neuroblocking platform for treating a range of acute and chronic gastrointestinal and metabolic diseases mediated by the vagus nerve.
ir.enteromedics.com
EnteroMedics® Inc. - Corporate Governance
http://ir.enteromedics.com/governance.cfm
Annual Reports and Proxy. The Board of Directors of EnteroMedics. Nominating and Governance Committee Charter. Code of Conduct and Ethics. Add file to Briefcase. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Annual Reports and Proxy.
EnteroMedics® Inc. - SEC Filings
http://ir.enteromedics.com/sec.cfm
Annual Reports and Proxy. Aug 17, 2016. Aug 17, 2016. Aug 17, 2016. Aug 12, 2016. Aug 4, 2016. Jul 20, 2016. Jul 15, 2016. Jul 6, 2016. Lea, gregory s. Jun 28, 2016. Shikora, scott a. Jun 28, 2016. Jun 28, 2016. Jun 28, 2016. Jun 9, 2016. Delange, peter m. Jun 6, 2016. May 27, 2016. May 19, 2016. Gladney, dan w. May 18, 2016. May 17, 2016. May 13, 2016. May 10, 2016. Showing 1-20 of 674. Add PDF file to Briefcase. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212.
EnteroMedics® Inc. - Press Releases
http://ir.enteromedics.com/releases.cfm
For press inquiries, please contact:. EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors. Aug 17, 2016. ST PAUL, Minn., Aug. 17, 2016 /PRNewswire/ - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, today announced the appointment of Gary Blackford to its Board of Directors, effective August 16, 2016. The Company also announce. Aug 15, 2016. Aug 4, 2016.
EnteroMedics® Inc. - Newsroom
http://ir.enteromedics.com/pressroom.cfm
For press inquiries, please contact:. Welcome to the EnteroMedics. Press room. This resource is intended for media professionals and investors who would like to learn more about EnteroMedics and VBLOC. Aug 17, 2016. EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors. Aug 15, 2016. EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery. Aug 4, 2016. EnteroMedics Reports Second Quarter 2016 Financial Results. TEL: 651.634.3003.
EnteroMedics® Inc. - Events
http://ir.enteromedics.com/events.cfm
Annual Reports and Proxy. Details on upcoming events are not yet available. Jun 1, 2016. EnteroMedics Commercial Update Call. Mar 15, 2016. 28th Annual ROTH Conference. Feb 17, 2016. ETRM Fourth Quarter 2015 Earnings Call. Dec 21, 2015. Dec 17, 2015. Year-End Financial Results and Business Update. Nov 19, 2015. Canaccord Genuity 2015 Medical Technology and Diagnostics Forum. Aug 13, 2015. Canaccord Genuity 35th Annual Growth Conference. Aug 6, 2015. ETRM Second Quarter 2015 Earnings Call. Mar 10, 2015.
TOTAL PAGES IN THIS WEBSITE
15
Enteromedics > USA
http://www.enteromedics.com/usa/obesity.asp
Given the limitations of transient and punitive procedures for the treatment of obesity, there continues to be a significant unmet need for a positive and more encouraging optionspecifically:. A physiologic obesity treatment that helps patients succeed in their efforts to lose weight and keep it off, while controlling the co-morbidities of their obesity. An option that does not require compromises in safety, nutrition, lifestyle, food choices or anatomy. 2800 Patton Road - St. Paul, MN 55113 USA.
Enteromedics > Careers at Enteromedics
http://www.enteromedics.com/careers/default.asp
Headquartered in St. Paul, Minnesota, EnteroMedics employs dedicated professionals across the USA with vast experience in clinical research, technology development, quality processes, sales, regulatory oversight, and business operations. Medical, Dental, Vision and Flex Benefits. Paid Vacation and Holidays. Summer Hours and year end shut down. Company sponsored Life and AD&D Insurance and Voluntary life Insurance. Business Casual Dress environment. 2800 Patton Road - St. Paul, MN 55113 USA.
Enteromedics > International > Obesity
http://www.enteromedics.com/international/obesity.asp
Addressing an Unmet Need. Given the limitations of transient and punitive procedures for the treatment of obesity, there continues to be a significant unmet need for a positive and more encouraging option, specifically:. A physiologic obesity treatment that helps patients succeed in their efforts to lose weight and keep it off, while controlling the co-morbidities of their obesity. An option that does not require compromises in safety, nutrition, lifestyle, food choices or anatomy.
Enteromedics > Sitemap
http://www.enteromedics.com/sitemap/default.asp
Legal Notices and Disclaimers. Annual Reports and Proxy. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 06/06/2016 11:07:49 AM.
Enteromedics > Newsroom > Press Kit
http://www.enteromedics.com/newsroom/press_kit.asp
EnteroMedic's press kit may be used only by press agencies and journalists publishing articles specifically about EnteroMedic's Inc. and its products. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 05/10/2016 03:26:21 PM. Annual Reports and Proxy.
Enteromedics > International > VBLOC Maestro® Rechargeable System
http://www.enteromedics.com/international/vbloc_maestro_system.asp
Important Safety Information for Patients. Use of the Maestro Rechargeable System. EnteroMedics has significant experience with vBloc Therapy; more than 600 patients have been implanted with the Maestro System to date, some out to five years. Safety, efficacy and sustained weight loss with vBloc Therapy has been demonstrated in multiple clinical trials. The major components of the Maestro Rechargeable System include:. The Clinician Programmer connects to the Mobile Charger to enable clinicians to customi...
Enteromedics > International
http://www.enteromedics.com/international/default.asp
Important Safety Information for Patients. The Maestro Rechargeable System has received CE Mark for the treatment of obesity and Type 2 diabetes mellitus through improved glycemic control, and has been listed on the Australian Register of Therapeutic Goods (ARTG) by the Therapeutic Goods Administration (TGA) for supply in Australia. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 06/06/2016 11:07:47 AM. Annual Reports and Proxy.
Enteromedics > Careers at Enteromedics > Employment Opportunities
http://www.enteromedics.com/careers/opportunities.asp
EnteroMedics employs dedicated professionals with vast experience in clinical research, technology development, quality processes, regulatory oversight, and business operations. EnteroMedics is focused on providing our employees with an exciting, dynamic work environment and opportunities for professional growth. We strive to provide competitive benefits and compensation to our employees, and we monitor the market to address changes in employee needs. Currently, there are no open employment opportunities.
Enteromedics > International > Clinical Experience
http://www.enteromedics.com/international/clinical_experience.asp
Learn more about our clinical experience in:. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 06/06/2016 11:07:47 AM. Annual Reports and Proxy.
Enteromedics > Newsroom > Press Kit
http://www.enteromedics.com/newsroom/vbloc_in_the_news.asp
VBloc In the News. EnteroMedics did not create and does not control the content contained in the following links. Refer to the Important Safety Information. For current information on indications and use of vBloc Therapy. Abc7NY Health and Fitness. VBloc Therapy featured in WebMD’s Future of Health hosted by Robin Roberts. New York Times (F.D.A. Approves Surgical Implant to Treat Obesity). Reuters (FDA approves EnteroMedics' novel device to treat obesity). 2800 Patton Road - St. Paul, MN 55113 USA.
TOTAL LINKS TO THIS WEBSITE
95
Investor Relations :: Energy XXI Gulf Coast, Inc. (EGC)
Keep up to Date and Stay Informed. Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox. Sign me up for:. Annual & Qtr Reports. Energy XXI Gulf Coast Announces Fourth Quarter and Full Year 2017 Financial and Operational Results. Mar 16, 2018. Fiscal Year Ended Dec 31, 2017. Fiscal Year Ended Dec 31, 2017. Stay informed and receive company updates straight to your inbox. Scotia Howard Weil Annual Energy Conference.
enerxy: Daten & Fakten
Enerxy AG: Bekanntmachung der Einberufung zur Hauptversammlung am 21.07.2015 in Stuttgart mit dem Ziel der europaweiten Verbreitung gemäß 121 AktG mehr. CDAX, General Standard. Golden Tiger Investment Ltd. Bezugsangebot an die Aktionäre der Business Media China AG.
ir.english.lc
ENN Energy Holdings Limited
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2016. Next Day Disclosure Return. Next Day Disclosure Return. Offer to Purchase for Cash of up to US$349,457,000 in Principal Amount of US$750,000,000 6.00% Senior Notes Due 2021 (the "NOTES") (i) Results of The Tender Offer as of The Expiration Date (ii) Expected Settlement Date. Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2016.
Ensogo
News & Announcements. News & Press Releases. Strong presence in 6 of the largest. E-commerce markets in the region. Providing over 12,000 offers and sales events. Reaching over 7.4 Million subscribers in SEA and Hong Kong. Ensogo is a leading e-Commerce business in the South East Asia and Hong Kong region, specialising in flash sales. Ensogo is a leading e-Commerce business in the South East Asia and Hong Kong region, specialising in flash sales. Click here for more stock detail. Sign up for Newsletter.
EnteroMedics® Inc. - Overview
Annual Reports and Proxy. EnteroMedics Inc. (NASDAQ: ETRM) has developed a novel medical device with the potential to advance weight loss treatment and address the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. EnteroMedics is committed to advancing the scientific, medical and commercial potential of VBLOC vagal blocking therapy, the Companys proprietary neuroblocking technology, to benefit patients, health care providers and ...Aug 6, 2015.
Overview | Investor Relations | Entropic
Cable Set-Top Box SoC Solutions. MoCA in CE Applications. Satellite Outdoor Unit Solutions. Satellite Set-Top Box SoC Solutions. Telco IPTV MoCA Solutions. Telco IPTV Set-Top Box SoC Solutions. IR Events and Presentations. Data as of 05/29/15 4:00 pm ET. Minimum 20 minute delay. Entropic Reports Preliminary Financial Results for the First Quarter 2015. Entropic c.LINK1.1 Access Solution to Deploy With Tianjin Broadcast and TV Network Co. Entropic MoCA is essential to distributing IPTV services within the...
Envestnet | Investor Overview
Register as New User. Advisors to Foundations and Endowments. Advisors to Retirement Plans. Bank and Trust Advisors. Bank and Bank Trust Departments. Advisors to Retirement Plans. Q2 2015 Envestnet, Inc. Earnings Conference Call. 160;at 5:00 pm ET. Q2 2015 Envestnet, Inc. Earnings Conference Call. Monday, August 10, 2015 . 5:00 pm ET . Click here for webcast. Click here to add this event to your calendar. Click here for Annual Meeting and Proxy Information. We are a leading independent provider of techn...
EnviroStar, Inc. (EVI)
Sep 30, 2016. Nov 30, 2016. EnviroStar, Inc. Announces a Special Cash Dividend. Nov 14, 2016. EnviroStar, Inc. Reports First Quarter Results. Oct 11, 2016. EnviroStar, Inc. Announces Completion of the Acquisition of Western State Design LLC. Sep 19, 2016. EnviroStar, Inc. Announces Year End Results. Sign up for email alerts. Be the first to receive breaking news. Financials at a Glance.
Enviva Investor Relations |
Wood Fiber Resource Overview. Ethics and Compliance Hotline. Enviva Partners, LP (NYSE: EVA) is a publicly-traded master limited partnership that aggregates a natural resource, wood fiber, and processes it into a transportable form, wood pellets. Our customers use our product to replace coal in power generation. We sell a significant majority of our wood pellets through long-term, take-or-pay agreements with creditworthy customers in the United Kingdom and Europe. 12/14/16 5:04 pm EST. 11/3/16 6:54 am EDT.
Envivio, Inc. - Overview
NASDAQ: ENVI) 4.10 *. Oct 26, 2015 at 4:00 PM ET). Vol: N/A * Delayed 20 min. By eSignal. Financial and News Releases. Charters and Governance Policies. Sign up to receive. Get a Quick Look at. A Catalyst for New Business Opportunities. Oct 8, 2015. Envivio Software Earns Multiple Accolades as a Leader in Streaming Media. Sep 10, 2015. Ericsson Announces Agreement to Acquire Envivio, Inc. Sep 8, 2015. Envivio and Dolby to Showcase Stunning, Live Ultra HD With High Dynamic Range at IBC.
SOCIAL ENGAGEMENT